You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 301 to 325 of about 5897
Next 25
07/04/2023
Copay Assistance Program is now open!
07/01/2023
Share Your Experiences With Glioblastoma Multiforme (GBM)
Plus Therapeutics Releases Early-Cut Data From Cancer Studies For Brain Cancer Settings
06/30/2023
Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma
06/29/2023
Mechanism of Action of KL-50, a Novel Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers
06/22/2023
1000 Patients Treated With GammaTile Therapy
06/21/2023
xCures and DDRFA partner to make an impact on patient-driven DIPG & DMG research
Quick survey on your brain tumor knowledge!
06/20/2023
AANS/CNS Section on Tumors and the World Federation of Neurosurgical Societies are hosting a GBM symposium
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial
06/18/2023
Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in "extreme" neurosurgical conditions
Senators introduce legislation to lower cost of cancer treatments
06/17/2023
GammaTile® (GT) as a brachytherapy platform for rapidly growing brain metastasis
06/12/2023
Stanford Scientists Identify Genes Linked to Familial Brain Cancer
Dr Henry Friedman podcast
06/08/2023
Senators Braun, Gillibrand, colleagues introduce bipartisan Promising Pathway Act to help patients with ALS and other life-threatening diseases get treatments
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial
06/05/2023
Brain Tumor Biotech Summit 2023 - this Friday June 9, 2023
Use of proton pump inhibitors (PPI) in glioblastoma (GBM) and relationship to overall survival in a national real-world evidence (RWE) database.
06/04/2023
Vorasidenib first ‘game changer’ in 20 years for patients with IDH-mutant grade 2 glioma
DCVax®-L: Mechanism of Action, Immunological Effects, and Clinical Trial External Controls Methodology
05/30/2023
GT Medical Technologies Marks a Clinical Milestone: 200th Patient Enrolled in the Multicenter Observational Registry of GammaTile® Therapy
Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort study
05/22/2023
Updated NCCN Guidelines for Brain Tumors
New legislation proposed to expedite FDA approval process for life-threatening disease treatments